Medivir to raise SEK 300 million
This article was originally published in Scrip
Executive Summary
Medivir is to conduct a rights offering of SEK 300 million (£27.6 million). The proceeds will be used to advance in-house projects, strengthen the company's commercial organisation and invest in additional research projects.